Growth hormone therapy in high-risk pediatric populations: Integrated growth, metabolic, and safety outcomes in SGA, preterm, and Russell–silver syndrome
Crossref DOI link: https://doi.org/10.30574/wjarr.2025.28.2.3819
Published Online: 2025-11-30
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
T. Soliman, Ashraf
Alyafei, Fawzia
M. Alaaraj, Nada
M. Ahmed, Shayma
S. AlHumaidi, Noora
Hamed, Noor
S. Elawwa, Ahmed
Khalil, Ahmed
